The global reproductive genetics market size reached US$ 5.7 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 50.1 Billion by 2032, exhibiting a growth rate (CAGR) of 27.3% during 2023-2032. The growing awareness and understanding of genetic disorders among the masses, the rising adoption of preventive healthcare, and the increasing fertility rates leading to a higher uptake of assisted reproductive technologies (ART) represent some of the key factors driving the market.
Reproductive genetics refers to the branch of genetics that focuses on the study of genetic information and its impact on reproductive health and outcomes. It involves the analysis and understanding of genetic factors related to fertility, pregnancy, and the transmission of genetic disorders from parents to their offspring. Reproductive genetics encompasses various techniques and technologies aimed at identifying and managing genetic conditions during the reproductive process. Screening individuals or couples for specific genetic mutations or carrier status to assess the risk of passing on genetic disorders to their children. In assisted reproductive technologies such as in vitro fertilization (IVF), PGD involves the analysis of embryos for genetic abnormalities before their implantation in the uterus, helping to select embryos without specific genetic disorders. Reproductive genetics helps assess the risk of transmitting genetic disorders to offspring by identifying carrier status or the presence of specific genetic mutations in individuals or couples.
Reproductive genetics refers to the branch of genetics that focuses on the study of genetic information and its impact on reproductive health and outcomes. It involves the analysis and understanding of genetic factors related to fertility, pregnancy, and the transmission of genetic disorders from parents to their offspring. Reproductive genetics encompasses various techniques and technologies aimed at identifying and managing genetic conditions during the reproductive process. Screening individuals or couples for specific genetic mutations or carrier status to assess the risk of passing on genetic disorders to their children. In assisted reproductive technologies such as in vitro fertilization (IVF), PGD involves the analysis of embryos for genetic abnormalities before their implantation in the uterus, helping to select embryos without specific genetic disorders. Reproductive genetics helps assess the risk of transmitting genetic disorders to offspring by identifying carrier status or the presence of specific genetic mutations in individuals or couples.
Reproductive Genetics Market Trends:
The global market is primarily driven by the growing awareness and understanding of genetic disorders among the masses. Also, the rising adoption of preventive healthcare leading to a higher number of prospective parents undergoing genetic testing to understand the risks of genetic disorders in their future children is fueling the market. With the increasing fertility rates, there is a higher uptake of assisted reproductive technologies (ART) such as In-Vitro Fertilization (IVF) and surrogacy, which is creating a positive market outlook. In line with this, continual technological developments in advanced genetic testing techniques such as Next-Generation Sequencing (NGS) and high-resolution microarrays are stimulating the market. Moreover, the increasing maternal age resulting in a higher susceptibility of chromosomal abnormalities in women is providing an impetus to the market. In addition to this, governments of several countries are increasingly supporting genetic research and testing, thereby catalyzing the growth of the market. The market is further driven by the rising affordability of genomic sequencing procedures, resulting in higher accessibility among the masses. Some of the other factors contributing to the market include inflating income levels, particularly in developing countries, the proliferation of organizations offering direct-to-consumer genetic tests, continual innovations in personalized medicine, and extensive research and development (R&D) activities.Key Market Segmentation:
The publisher provides an analysis of the key trends in each segment of the global reproductive genetics market, along with forecasts at the global, regional, and country levels from 2024-2032. The report has categorized the market based on product type, procedure type, technology and application.Product Type Insights:
- Kits
- Laboratory Developed Tests (LDT)
- Reagents and Consumables
Procedure Type Insights:
- Carrier Screening
- Pre-Natal Screening
- Pre-Implantation Genetic Testing
- Infertility Genetic Testing
Technology Insights:
- Next-Generation Sequencing
- Polymerase Chain Reaction
- In Situ Hybridization (ISH/FISH)
- Microarray
Application Insights:
- Aneuploidy
- Structural Chromosomal Abnormality
- Single Gene Disorder
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global reproductive genetics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bangkok Genomics Innovation Public Company Limited, Centogene N.V., Fulgent Genetics Inc., Igenomix (Vitrolife Group), Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.Key Questions Answered in This Report:
- How has the global reproductive genetics market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global reproductive genetics market?
- What is the impact of each driver, restraint, and opportunity on the global reproductive genetics market?
- What are the key regional markets?
- Which countries represent the most attractive reproductive genetics market?
- What is the breakup of the market based on the product type?
- Which is the most attractive product type in the reproductive genetics market?
- What is the breakup of the market based on the procedure type?
- Which is the most attractive procedure type in the reproductive genetics market?
- What is the breakup of the market based on the technology?
- Which is the most attractive technology in the reproductive genetics market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the reproductive genetics market?
- What is the competitive structure of the global reproductive genetics market?
- Who are the key players/companies in the global reproductive genetics market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Reproductive Genetics Market
6 Market Breakup by Product Type
7 Market Breakup by Procedure Type
8 Market Breakup by Technology
9 Market Breakup by Application
10 Market Breakup by Region
11 Drivers, Restraints, and Opportunities
13 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Bangkok Genomics Innovation Public Company Limited
- Centogene N.V.
- Fulgent Genetics Inc.
- Igenomix (Vitrolife Group)
- Invitae Corporation
- Laboratory Corporation of America Holdings
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 146 |
| Published | March 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 5.7 Billion |
| Forecasted Market Value ( USD | $ 50.1 Billion |
| Compound Annual Growth Rate | 27.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
